Samlyn Capital, LLC Global Blood Therapeutics, Inc. Transaction History

Samlyn Capital, LLC

  • $6.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$32.46 - $43.42 $18.4 Million - $24.7 Million
-568,183 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$38.94 - $50.85 $3.84 Million - $5.01 Million
98,588 Added 20.99%
568,183 $23.2 Million
Q4 2020

Feb 16, 2021
BUY
$37.65 - $63.77 $17.7 Million - $29.9 Million
469,595 New
469,595 $20.3 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Samlyn Capital, LLC Portfolio

Follow Samlyn Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email